Pamela Cox

A beloved New York beach club, profitable yet bankrupt, is for sale. It's a rare chance to own the coast, but what will become of its legacy?

The appointment of a top lawyer at a key compliance firm reveals how technology and human expertise are being fused to tame our most complex social safety nets.

Reolink's new AI cameras promise advanced protection without subscription fees, challenging an industry built on recurring costs and cloud data collection.

With the strategic hire of growth guru Jim Garrity, Symmatrics signals a pivotal shift from theoretical promise to market dominance in quantum security.

Pillar To Post's award-winning marketing isn't just about ads; it's a system for empowering local entrepreneurs to thrive in a volatile market.

A New York school district fixed a decades-old transportation crisis, saving $1M and boosting attendance. How did a tech partnership become the key?

An AI tool just received FDA clearance to quantify Alzheimer's biomarkers in brain scans. It promises earlier answers, but raises profound questions for patients and our healthcare system.

Denver-based MegaSurge Capital is testing the waters in Europe, but a complex market and questions about its own profile create a high-stakes scenario.

A new patent for its E-Motion™ powertrain isn't just about IP; it's a strategic move to lock down safety, secure OEM deals, and define the future.

LEDVANCE's latest innovations, recognized by industry experts, aren't just brighter bulbs. They are systemic tools for safety and efficiency in extreme environments.

With a novel drug platform and new funding, Akari Therapeutics aims to redefine cancer therapy. But can its groundbreaking science outpace a ticking financial clock?

With a $115M financing and an expanded pipeline, Assembly Biosciences is betting on novel therapies for liver and viral diseases. But can it navigate a crowded field?

After years of volatility, used car prices are finally stabilizing. But with household debt at record highs, this market shift reveals a deeper economic truth.

A private equity firm's acquisition of a wastewater company reveals a deeper story about water scarcity, reshoring, and the systems we need to thrive.

Modular home innovator Boxabl is calling for M&A across the housing industry. Is this a bold plan to solve the affordability crisis or a risky consolidation play?

With key FDA backing and promising clinical data, Allogene Therapeutics is advancing a vision where complex cell therapies are not just for major medical centers.

A small firm is connecting ChatGPT to old walkie-talkies, democratizing AI for first responders and small businesses without costly hardware upgrades.

A biotech's new funding offers a glimmer of hope for a novel cancer therapy, but a look at the books reveals a desperate race against time and capital.

Pason Systems' Q2 results reveal a company thriving not just on market tailwinds, but on strategic tech investments and operational leverage in a complex energy sector.

Kyoto Fusioneering and Oak Ridge National Laboratory are building UNITY-3, a facility to solve fusion's biggest engineering hurdle and anchor a new energy hub.